Skip to search
Skip to main content
Back to Search
Start Over
Efficacy and safety of paritaprevir/r/ombitasvir/dasabuvir +/- ribavirin in genotype 1 HCV infected patients treated in real life settings (AMBER study)
Authors :
Flisiak, R. Janczewska, E. Wawrzynowicz-Syczew, M. Wiercinska-Drapalo, A. Zarebska-Mich, D. Bolewska, B. Fleischer-Stepniewska, K. Tomasiewic, K. Rostkowska, K. Karwowska, K. Piekarska, A. Tronina, O. Pisula, A. Mariusz Łucejko Karpinska, E. Nazzal, K. Kryczka, W. Mozer-Lisewska, I. Knysz, B.
Source :
ResearcherID, Web of Science
Details
Database :
OpenAIRE
Journal :
ResearcherID, Web of Science
Accession number :
edsair.dedup.wf.001..31c3fe7835ef821145ddd0db2208775c